Major depressive disorder (MDD), single episode, moderate, is a clinical diagnosis characterized by a period of at least two weeks during which there is either depressed mood or the loss of interest or pleasure in nearly all activities. In a moderate episode, the individual typically exhibits a greater number of symptoms or more significant functional impairment than seen in mild cases, but without the extreme incapacitation or psychotic features often present in severe episodes. Patients often experience significant difficulty in continuing with social, work, or domestic activities, though they may still be able to function at a basic level. The diagnosis requires that the episode is not better explained by a schizoaffective disorder and is not superimposed on schizophrenia, schizophreniform disorder, delusional disorder, or other specified or unspecified schizophrenia spectrum and other psychotic disorders. Additionally, there must be no history of a manic episode or a hypomanic episode.
Distinguish between single and recurrent episodes by reviewing longitudinal history of depressive symptoms and previous treatment response.
Example: Patient presents with first lifetime occurrence of pervasive low mood and anhedonia lasting 6 weeks. No prior history of similar episodes or antidepressant use. MDD, single episode, moderate. Billing Focus: Single episode status. Risk Adjustment: Captures initial incident severity for HCC profiling.
Billing Focus: Single episode status
Document specific PHQ-9 scores to support the moderate severity classification, typically ranging from 10 to 14.
Example: Current PHQ-9 score is 13, consistent with moderate depressive symptoms including sleep disturbance and poor concentration. MDD, single episode, moderate. Billing Focus: Clinical severity level. Risk Adjustment: Justifies higher resource utilization for moderate versus mild disease.
Billing Focus: Clinical severity level
Explicitly state the absence of psychotic features such as hallucinations or delusions to differentiate from severe episodes.
Example: Patient reports significant fatigue and worthlessness but denies any auditory or visual hallucinations; no evidence of delusional thinking. MDD, single episode, moderate. Billing Focus: Exclusion of psychosis (F32.3). Risk Adjustment: Ensures accurate severity tiering for risk-based contracts.
Billing Focus: Exclusion of psychosis (F32.3)
Identify the specific functional impairments caused by the depressive episode, such as occupational or social difficulties.
Example: Patient reports difficulty completing work assignments and withdrawal from family activities due to lack of energy. MDD, single episode, moderate. Billing Focus: Manifestation of symptoms. Risk Adjustment: Documents functional decline relevant to Medicare Advantage risk scoring.
Billing Focus: Manifestation of symptoms
Differentiate from adjustment disorders by assessing the duration and intensity of symptoms beyond an identifiable stressor.
Example: Symptoms of moderate depression have persisted for 3 months, exceeding the typical duration and severity of a localized adjustment reaction. MDD, single episode, moderate. Billing Focus: Differential diagnosis clarity. Risk Adjustment: Major depression carries a higher risk weight than adjustment disorder.
Billing Focus: Differential diagnosis clarity
Document the presence or absence of suicidal ideation to further support the clinical decision-making complexity.
Example: Patient denies active suicidal ideation or intent but expresses frequent feelings of hopelessness. MDD, single episode, moderate. Billing Focus: Medical decision making complexity. Risk Adjustment: Supports complexity of management in the Hierarchical Condition Category model.
Billing Focus: Medical decision making complexity
Primary procedure for establishing the initial diagnosis of F32.1.
Standard therapeutic intervention duration for treating moderate MDD.
Typically used when managing moderate depression with medication adjustments and comorbidities.
Appropriate for stable patients with moderate MDD on a maintenance medication regimen.
Used for PHQ-9 administration to objectively quantify moderate severity.
Utilized for intensive sessions involving complex life stressors or severe functional impairment.
Add-on code for medication management during therapy sessions.
Standard for a first-time evaluation of a patient presenting with moderate depressive symptoms.
Commonly used for medication side-effect checks or crisis check-ins.
Supports the collaborative care model for managing moderate depression.